Finally, we suggest that future studies consider assessing the HPA axis using expanded and complementary laboratory strategies, such as insulin-mediated hypoglycemia stimulation tests; CRH stimulation tests; or a combination of hair, saliva and/or blood measurements. The gene discussed is INS; the disease is Hypoglycemia.